Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

Innate Immunity Stimulation Via TLR9 in Early AD

Phase 1

Recruiting

Conditions: Mild Cognitive Impairment
Alzheimer Dementia

Interventions: Drug: Placebo
Drug: CpG1018

First Posted Date: 2022-11-04

Last Posted Date: 2025-02-26

Lead Sponsor: NYU Langone Health

Target Recruit Count: 15

Registration Number: NCT05606341

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Care Partner-Assisted Diabetes Self-Management Through Linking Continuous Glucose Monitoring With Mobile Health: Improving Outcomes for Older Adults With Mild Cognitive Impairment

Phase 1

Recruiting

Conditions: Type 2 Diabetes
Mild Cognitive Impairment

Interventions: Device: Continuous Glucose Monitor (CGM)

First Posted Date: 2022-11-01

Last Posted Date: 2024-12-02

Lead Sponsor: NYU Langone Health

Target Recruit Count: 20

Registration Number: NCT05601583

Locations: 🇺🇸
Bellevue Hospital, New York, New York, United States

Pulmonary Embolism - Thrombus Removal With Catheter-Directed Therapy

Phase 3

Recruiting

Conditions: Pulmonary Embolism

Interventions: Drug: Anticoagulant Therapy
Device: Catheter-Directed Therapy

First Posted Date: 2022-10-24

Last Posted Date: 2025-04-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 500

Registration Number: NCT05591118

Locations: 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
Promedica, Toledo, Ohio, United States
🇺🇸
Advocate Good Samaritan Hospital, Downers Grove, Illinois, United States

and more 37 locations

Addressing Health Disparities in Chronic Low Back Pain With Patient-Clinician Relatedness

Not Applicable

Completed

Conditions: Chronic Low-Back Pain

Interventions: Other: Enhanced Relationship
Other: Limited Relationship

First Posted Date: 2022-10-14

Last Posted Date: 2023-06-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 56

Registration Number: NCT05580380

Locations: 🇺🇸
New York University Department of Physical Therapy, Arthur J. Nelson Human Performance Laboratory, New York, New York, United States

Timing of Bridge Plate Removal and Distal Radius Fracture Outcomes

Not Applicable

Withdrawn

Conditions: Distal Radius Fracture

Interventions: Procedure: Dorsal Spanning Bridge Plate Fixation
Procedure: Dorsal Spanning Bridge Plate Removal

First Posted Date: 2022-10-13

Last Posted Date: 2024-12-24

Lead Sponsor: NYU Langone Health

Target Recruit Count: 100

Registration Number: NCT05578612

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33

Not Applicable

Recruiting

Conditions: Major Depressive Disorder

Interventions: Device: Transcranial Photobiomodulator
Device: Sham

First Posted Date: 2022-10-10

Last Posted Date: 2025-03-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 120

Registration Number: NCT05573074

Locations: 🇺🇸
Harvard Medical School, Boston, Massachusetts, United States
🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
Nathan Kline Institute for Psychiatric Research, Orangeburg, New York, United States

Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

Phase 2

Recruiting

Conditions: Social Anxiety Disorder

Interventions: Drug: Placebo
Drug: Cannabidiol

First Posted Date: 2022-10-07

Last Posted Date: 2025-05-09

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT05571592

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Safety of the Herpes Zoster Subunit Vaccine in Lupus

Phase 4

Recruiting

Conditions: Systemic Lupus Erythematosus

Interventions: Biological: Herpes Zoster Subunit (HZ/su) Vaccine
Biological: Placebo

First Posted Date: 2022-09-29

Last Posted Date: 2025-02-05

Lead Sponsor: NYU Langone Health

Target Recruit Count: 224

Registration Number: NCT05559671

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States

Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease

Not Applicable

Not yet recruiting

Conditions: End Stage Kidney Disease

Interventions: Dietary Supplement: Standard Table Salt
Dietary Supplement: Salt Substitute

First Posted Date: 2022-09-28

Last Posted Date: 2025-04-18

Lead Sponsor: NYU Langone Health

Target Recruit Count: 20

Registration Number: NCT05558267

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

Efficacy of STABL Virtual Rehabilitation

Not Applicable

Recruiting

Conditions: Physical Therapy

Interventions: Behavioral: STABL Virtual Rehabilitation

First Posted Date: 2022-09-27

Last Posted Date: 2024-07-01

Lead Sponsor: NYU Langone Health

Target Recruit Count: 60

Registration Number: NCT05556850

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy